search
Back to results

Study of Effectiveness of Pold in Chronic Nonspecific Low Back Pain (Pold-LBP)

Primary Purpose

Mechanical Low Back Pain

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Resonant oscillation
column exercise group
Sponsored by
Omphis Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mechanical Low Back Pain

Eligibility Criteria

25 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Having a diagnosis instrumental prior to treatment to rule out pathologies pollutants, neurological or structural malformations.
  • No previous trauma.
  • Age between 25 and 65.
  • With similar clinical characteristics to have a homogenous group:

    • Low back pain (> 3 months) and that at the time the study began have a minimum of 3/10 on VAS scale, following the criteria established in similar studies
    • without component of neurological lower limbs irradiation

Exclusion Criteria:

  • Existence of other recent traumatic structural pathologies in the lumbar region or of another type that could disturb the study.
  • Existence of irradiation metameric to lower limbs
  • Current tumors in the lumbar region
  • Ongoing infectious disease in the lumbar area.
  • Inflammatory rheumatism in the lumbar region.
  • Lumbar surgery complications.
  • Ongoing pregnancy.
  • They have been treated with infiltrations in the last month.
  • Who are following any other treatment, whether manual or physical agents or alternative or complementary therapies.

Sites / Locations

  • Esperanza Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

POLD TREATMENT

CONVENCIONAL: column exercise group

Arm Description

Patients who applies the treatment of resonant oscillation according to the Pold Concept

Patients who applied the conventional treatment of hospital

Outcomes

Primary Outcome Measures

VAS pain measurement
Visual analog scale of pain measurement, with values between zero and ten where zero is total absence of pain and 10 the maximum pain imaginable by the patient, distributed in a horizontal line, without intermediate numerical or graphic references.

Secondary Outcome Measures

SF-12 Health Survey
The Health Questionnaire SF-12 is the adaptation made for Spain of the SF-12 Health Survey. The SF-12 is a reduced version of the SF-36 Health Questionnaire. This instrument provides a profile of the state of health and is one of the most widely used generic scales in the evaluation of clinical outcomes, being applicable both for the general population and for patients with a minimum age of 14 years and both in descriptive studies and in evaluation. It consists of 12 items from the 8 dimensions of SF-36: Physical Function (2), Social Function (1), Physical Role (2), Emotional Role (2), Mental Health (2), Vitality (1), Pain body (1), General Health (1). Response options form Likert-type scales that evaluate intensity or frequency. The number of response options ranges from three to six, depending on the item
Oswestry Disability Index
The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic. The patient then checks the statement which most closely resembles their situation. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

Full Information

First Posted
May 1, 2012
Last Updated
April 5, 2019
Sponsor
Omphis Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT01591824
Brief Title
Study of Effectiveness of Pold in Chronic Nonspecific Low Back Pain
Acronym
Pold-LBP
Official Title
Effectiveness of Resonant Oscillation, According to the Pold Concept in Chronic Nonspecific Low Back Pain
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
July 2015 (Actual)
Study Completion Date
September 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Omphis Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Through this research is to conduct a pilot clinical trial in the treatment of chronic nonspecific low back pain (degenerative and mechanical), by comparing two groups, one that will apply a technique of physiotherapy by passive movement of the column with oscillations in axial rotation at a frequency of 1.5 to 2 cps (resonance) of low amplitude (called "Pold Concept"), another group that applies the standard protocol of treatment for this condition, as used in the hospital where performed the study. It will compare the levels of efficiency and effectiveness of each treatment and the comparison between them. This will measure the perception of pain intensity and disability.
Detailed Description
Type of study: This is an analytical study, the experimental group clinical trial type, controlled, randomized with complete randomization and single blind. Two groups, the study to which the POLD treatment shall apply, and the control group with conventional treatment will be formed by complete randomization system as they arrive for consultation, with a total of 50 patients or more if they were needed for each group have a minimum of 25 having offset dropouts. The number of 25 patients per group is determined considering accepting an alpha risk of 0.05 and a beta risk of 0.20 in a bilateral contrast, are required at least 21 subjects in each group to detect a minimum difference of 15 percentage points between the two groups, therefore two groups of 25 assuming a standard deviation of 15 points and a loss rate of 0% tracking form. We will study both the effectiveness and efficiency individually and comparatively between groups. Study population: The sample was selected from patients attending the clinic with back pain and after medical diagnosis are referred to the physiotherapist report of diagnosis, prescribing physical therapy and who meet the criteria for inclusion and not exclusion . A total of 25 patients in the experimental group and 25 for the standard treatment group are selected. If losses to the sample will be replaced by others to maintain proportions. The selection of groups: RANDOM will be used , he formed the experimental group and control directing patients overall are being incorporated randomly according to the study : 1. Group A ( study ) will apply the technique with an identical protocol POLD them all. 2. Group B (conventional control) was applied average conventional treatment of different physiotherapy centers of reference. Study variables to collect: Subjective assessment of pain intensity using VAS, visual analog pain. , Evolution of disability by Oswestry test. SF-12 on health. Statistical analysis: Computer analysis using "SPSS" 13.0 ® processed program. The study will be processed as follows: First, an initial analysis was performed to verify that there were no significant differences between groups in baseline values of the dependent variables by Student's t test for independent samples. Second : For each dependent variable variance analysis is applied using a general linear model with 2x10 between subjects factor we call variable " Treatment " with two categories 1, 2 (experimental group = 1, conventional group = 2 ) and a temporal within-subjects factor we call "SHOOT" ( 10 sessions) . Third: We analyze to what treatment session the differences between the two groups appear by Student's t test for independent data after the first session Fourth, the interactions are studied by comparing the two groups after the first, fifth and 10th session using a Student t test for independent data and comparing the results of each group between 1st and 5th session and between 1st and 10th session with a Student t for paired data. • Ethical Issues: During the study of national and international guidelines (code of ethics, Declaration of Helsinki) will continue, likewise the legal regulations on data privacy (Law 15 /1999 of 13 December on the Protection of Personal Data)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mechanical Low Back Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
POLD TREATMENT
Arm Type
Experimental
Arm Description
Patients who applies the treatment of resonant oscillation according to the Pold Concept
Arm Title
CONVENCIONAL: column exercise group
Arm Type
Active Comparator
Arm Description
Patients who applied the conventional treatment of hospital
Intervention Type
Other
Intervention Name(s)
Resonant oscillation
Other Intervention Name(s)
oscillatory movement
Intervention Description
Resonant sustained oscillations are applied in the following areas general column. lumbar muscles, and paraspinal muscles, sacral decompression oscillatory Opening by lateral vertebral lumbar rhythmic swing. Balancing and pelvic decompression Swing-lumbar vertebral rotation.
Intervention Type
Other
Intervention Name(s)
column exercise group
Other Intervention Name(s)
motor control
Intervention Description
paraspinal muscle stretching exercises postural correction mobilization exercises thoracic and lumbar Motor control exercises
Primary Outcome Measure Information:
Title
VAS pain measurement
Description
Visual analog scale of pain measurement, with values between zero and ten where zero is total absence of pain and 10 the maximum pain imaginable by the patient, distributed in a horizontal line, without intermediate numerical or graphic references.
Time Frame
Participants will be followed for the duration of treatment application, an expected average of 3 weeks.
Secondary Outcome Measure Information:
Title
SF-12 Health Survey
Description
The Health Questionnaire SF-12 is the adaptation made for Spain of the SF-12 Health Survey. The SF-12 is a reduced version of the SF-36 Health Questionnaire. This instrument provides a profile of the state of health and is one of the most widely used generic scales in the evaluation of clinical outcomes, being applicable both for the general population and for patients with a minimum age of 14 years and both in descriptive studies and in evaluation. It consists of 12 items from the 8 dimensions of SF-36: Physical Function (2), Social Function (1), Physical Role (2), Emotional Role (2), Mental Health (2), Vitality (1), Pain body (1), General Health (1). Response options form Likert-type scales that evaluate intensity or frequency. The number of response options ranges from three to six, depending on the item
Time Frame
Participants will be followed for the duration of treatment application, an expected average of 3 weeks.
Title
Oswestry Disability Index
Description
The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic. The patient then checks the statement which most closely resembles their situation. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Time Frame
Participants will be followed for the duration of treatment application, an expected average of 3 weeks.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Having a diagnosis instrumental prior to treatment to rule out pathologies pollutants, neurological or structural malformations. No previous trauma. Age between 25 and 65. With similar clinical characteristics to have a homogenous group: Low back pain (> 3 months) and that at the time the study began have a minimum of 3/10 on VAS scale, following the criteria established in similar studies without component of neurological lower limbs irradiation Exclusion Criteria: Existence of other recent traumatic structural pathologies in the lumbar region or of another type that could disturb the study. Existence of irradiation metameric to lower limbs Current tumors in the lumbar region Ongoing infectious disease in the lumbar area. Inflammatory rheumatism in the lumbar region. Lumbar surgery complications. Ongoing pregnancy. They have been treated with infiltrations in the last month. Who are following any other treatment, whether manual or physical agents or alternative or complementary therapies.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
José M. Muniesa, physiatrist
Organizational Affiliation
Esperanza Hospital (Barcelona)
Official's Role
Study Director
Facility Information:
Facility Name
Esperanza Hospital
City
Barcelona
ZIP/Postal Code
08024
Country
Spain

12. IPD Sharing Statement

Links:
URL
http://www.omphis.es
Description
Click here for more information about Omphis Foundation activities, Clinic, teaching and research

Learn more about this trial

Study of Effectiveness of Pold in Chronic Nonspecific Low Back Pain

We'll reach out to this number within 24 hrs